BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  FORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib

  May 22, 2025

   · 

  6 min read
• Press Releases

  Auxilium Biotechnologies Launches Clinical Trial for Nerve Regeneration Medical Device

  May 22, 2025

   · 

  1 min read
• Press Releases

  PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

  May 22, 2025

   · 

  5 min read
• Press Releases

  Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting

  May 22, 2025

   · 

  5 min read
• Press Releases

  ulrich medical USA® Appoints Eric Gibbs as President and General Manager

  May 22, 2025

   · 

  2 min read
• Press Releases

  New Research Exposes Why Biotech’s Best Scientists Can’t Tell Companies Apart - And Reveals the Zero-Budget Fix That’s Already Working

  First-Ever Industry Analysis Shows 83% Message Overlap Forcing Biotechs Into Costly Talent Bidding Wars

  May 22, 2025

   · 

  1 min read
• Press Releases

  Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

  May 22, 2025

   · 

  5 min read
• Press Releases

  Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

  The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE

  May 22, 2025

   · 

  7 min read
• Press Releases

  Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

  May 22, 2025

   · 

  6 min read
• Press Releases

  Sofwave to Participate in Jefferies Global Healthcare Conference

  May 22, 2025

   · 

  1 min read